Intelligent Bio Solutions Files 8-K on Financials
Ticker: INBS · Form: 8-K · Filed: Aug 15, 2025 · CIK: 1725430
Sentiment: neutral
Topics: financial-reporting, results-of-operations, financial-statements
TL;DR
IBSI dropped an 8-K detailing financials and exhibits as of 8/15/25.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on August 15, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. The filing details the company's financial performance and provides updated exhibits for the period ending August 15, 2025. The company, formerly known as GBS Inc., is incorporated in Delaware and operates in the Surgical & Medical Instruments & Apparatus industry.
Why It Matters
This 8-K filing provides investors with crucial updates on Intelligent Bio Solutions Inc.'s financial health and operational results, impacting investment decisions.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant financial and operational updates that may affect a company's stock price, requiring careful investor review.
Key Players & Entities
- INTELLIGENT BIO SOLUTIONS INC. (company) — Registrant
- GBS Inc. (company) — Former Company Name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former Company Name
- August 15, 2025 (date) — Date of Report
FAQ
What specific financial results are detailed in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits' as of August 15, 2025, but the specific details of these results are not provided in the provided text.
When was the report filed and what is the earliest event date reported?
The report was filed on August 15, 2025, and the earliest event date reported is also August 15, 2025.
What are the former names of Intelligent Bio Solutions Inc. mentioned in the filing?
The filing states that the company was formerly known as GBS Inc. (since September 19, 2019) and prior to that, Glucose Biosensor Systems (Greater China) Holdings, Inc. (since December 14, 2017).
Where is Intelligent Bio Solutions Inc. headquartered?
The principal executive offices of Intelligent Bio Solutions Inc. are located at 135 West 41st Street, 5th Floor, New York, NY 10036.
What is the Standard Industrial Classification (SIC) code for Intelligent Bio Solutions Inc.?
The SIC code for Intelligent Bio Solutions Inc. is 3841, which corresponds to 'Surgical & Medical Instruments & Apparatus'.
Filing Stats: 531 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-08-15 17:00:30
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 73KB
- 0001493152-25-012101.txt ( ) — 285KB
- inbs-20250815.xsd (EX-101.SCH) — 3KB
- inbs-20250815_lab.xml (EX-101.LAB) — 33KB
- inbs-20250815_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 15, 2025 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer